Synthesis, characterization, and biological evaluation of new RU(ii) polypyridyl photosensitizers for photodynamic therapy

Journal of Medicinal Chemistry

Volumn 57, Issue 17, 2014, Pages 7280-7292

  Frei, Angelo ^a   Rubbiani, Riccardo ^a   Tubafard, Solmaz ^b   Blacque, Olivier ^a   Anstaett, Philipp ^a   Felgenträger, Ariane ^c   Maisch, Tim ^c   Spiccia, Leone ^b   Gasser, Gilles ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; AMINOLEVULINIC ACID; ANTIINFECTIVE AGENT; CISPLATIN; DIAZEPAM; IMIDAZOLE; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; RU(II) POLYPYRIDYL PHOTOSENSITIZER; RUTHENIUM COMPLEX; SILICON DIOXIDE; SINGLET OXYGEN; SODIUM; TOLUENE; UNCLASSIFIED DRUG; COORDINATION COMPOUND; RUTHENIUM;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL DEATH; CELL ORGANELLE; CELL VIABILITY; CELL VIABILITY ASSAY; CELLULAR DISTRIBUTION; CERVICAL CANCER CELL LINE; COLONY FORMING UNIT; COLUMN CHROMATOGRAPHY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; ESCHERICHIA COLI; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; LIMIT OF DETECTION; MASS SPECTROMETRY; MITOCHONDRION; NONHUMAN; PHOSPHORESCENCE; PHOTODYNAMIC THERAPY; PHOTOLUMINESCENCE; PHOTOSENSITIZATION; PHOTOTOXICITY; PLASMA; QUANTUM YIELD; STAPHYLOCOCCUS AUREUS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROSCOPY; X RAY CRYSTALLOGRAPHY; CELL LINE; CELL SURVIVAL; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; LIGHT; MICROBIAL VIABILITY; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; SYNTHESIS;

CELL LINE; CELL SURVIVAL; COORDINATION COMPLEXES; ESCHERICHIA COLI; HELA CELLS; HUMANS; LIGHT; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RUTHENIUM; STAPHYLOCOCCUS AUREUS;

EID: 84907180183     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm500566f     Document Type: Article

References (104)

1. Ferlay, J.; Soerjomataram, I.; Ervik, M.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D. M.; Forman, D.; Bray, F. Cancer Incidence and Mortality Worldwide; International Agency for Research on Cancer: Lyon, France, 2013.
2. Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Photodynamic therapy for cancer Nature Rev. Cancer 2003, 3, 380-387
3. Foote, C. S. Definition of type I and type II photosensitized oxidation Photochem. Photobiol. 1991, 54, 659-659
4. Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic Therapy J. Natl. Cancer Inst. 1998, 90, 889-905
5. Yang, J. Z.; Vugt, D. A. V.; Kennedy, J. C.; Reid, R. L. Intrauterine 5-aminolevulinic acid induces selective fluorescence and photodynamic ablation of the rat endometrium Photochem. Photobiol. 1993, 57, 803-807
6. Bonnett, R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy Chem. Soc. Rev. 1995, 24, 19-33
7. Allison, R. R.; Sibata, C. H. Oncologic photodynamic therapy photosensitizers: a clinical review Photodiagn. Photodyn. Ther. 2010, 7, 61-75
8. Hamblin, M. R.; Hasan, T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004, 3, 436-450
9. Tubby, S. The Effect of Light-Activated Antimicrobial Agents on Bacterial Virulence Factors and Key Modulators of Inflammation; University College London: London, 2011.
10. Tavares, A.; Carvalho, C. M. B.; Faustino, M. A.; Neves, M. G. P. M. S.; Tomé, J. P. C.; Tomé, A. C.; Cavaleiro, J. A. S.; Cunha, Â.; Gomes, N. C. M.; Alves, E.; Almeida, A. Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment Mar. Drugs 2010, 8, 91-105
11. Castano, A. P.; Demidova, T. N.; Hamblin, M. R. Mechanisms in photodynamic therapy: part one. Photosensitizers, photochemistry and cellular localization Photodiagn. Photodyn. Ther. 2004, 1, 279-293
12. Baas, P.; van Mansom, I.; van Tinteren, H.; Stewart, F. A.; van Zandwijk, N. Effect of N -acetylcysteine on photofrin-induced skin photosensitivity in patients Lasers Surg. Med. 1995, 16, 359-367
13. Levina, A.; Mitra, A.; Lay, P. A. Recent developments in ruthenium anticancer drugs Metallomics 2009, 1, 458-470
14. Bergamo, A.; Sava, G. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs Dalton Trans. 2011, 40, 7817-7823
15. Ang, W. H.; Casini, A.; Sava, G.; Dyson, P. J. Organometallic ruthenium-based antitumor compounds with novel modes of action J. Organomet. Chem. 2011, 696, 989-998
16. Kilah, N. L.; Meggers, E. Sixty years young: the diverse biological activities of metal polypyridyl complexes pioneered by Francis P. Dwyer Aust. J. Chem. 2012, 65, 1325-1332
17. Scolaro, C.; Bergamo, A.; Brescacin, L.; Delfino, R.; Cocchietto, M.; Laurenczy, G.; Geldbach, T. J.; Sava, G.; Dyson, P. J. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes J. Med. Chem. 2005, 48, 4161-4171
18. Dougan, S. J.; Habtemariam, A.; McHale, S. E.; Parsons, S.; Sadler, P. J. Catalytic organometallic anticancer complexes Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 11628-11633
19. Hartinger, C. G.; Jakupec, M. A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.; Zorbas, H.; Dyson, P. J.; Keppler, B. K. KP1019, a new redox-active anticancer agent-preclinical development and results of a clinical phase I study in tumor patients Chem. Biodiversity 2008, 5, 2140-2155
20. Bergamo, A.; Gaiddon, C.; Schellens, J. H. M.; Beijnen, J. H.; Sava, G. Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates J. Inorg. Biochem. 2012, 106, 90-99
21. Alessio, E.; Mestroni, G.; Bergamo, A.; Sava, G. Ruthenium antimetastatic agents Curr. Top. Med. Chem. 2004, 4, 1525-1535
22. Pernot, M.; Bastogne, T.; Barry, N. P. E.; Therrien, B.; Koellensperger, G.; Hann, S.; Reshetov, V.; Barberi-Heyob, M. Systems biology approach for in vivo photodynamic therapy optimization of ruthenium-porphyrin compounds J. Photochem. Photobiol., B 2012, 117, 80-89
23. Johnpeter, J. P.; Schmitt, F.; Denoyelle-Di-Muro, E.; Wagnieres, G.; Juillerat-Jeanneret, L.; Therrien, B. Photoactive sawhorse-type diruthenium tetracarbonyl complexes Inorg. Chim. Acta 2012, 393, 246-251
24. Zhang, J.-X.; Zhou, J.-W.; Chan, C.-F.; Lau, T. C.-K.; Kwong, D. W. J.; Tam, H.-L.; Mak, N.-K.; Wong, K.-L.; Wong, W.-K. Comparative studies of the cellular uptake, subcellular localization, and cytotoxic and phototoxic antitumor properties of ruthenium(II)-porphyrin conjugates with different linkers Bioconjugate Chem. 2012, 23, 1623-1638
25. Gianferrara, T.; Bergamo, A.; Bratsos, I.; Milani, B.; Spagnul, C.; Sava, G.; Alessio, E. Ruthenium-porphyrin conjugates with cytotoxic and phototoxic antitumor activity J. Med. Chem. 2010, 53, 4678-4690
26. Davia, K.; King, D.; Hong, Y.; Swavey, S. A porphyrin-ruthenium photosensitizer as a potential photodynamic therapy agent Inorg. Chem. Commun. 2008, 11, 584-586
27. Schmitt, F.; Govindaswamy, P.; Suess-Fink, G.; Ang, W. H.; Dyson, P. J.; Juillerat-Jeanneret, L.; Therrien, B. Ruthenium porphyrin compounds for photodynamic therapy of cancer J. Med. Chem. 2008, 51, 1811-1816
28. Charlesworth, P.; Truscott, T. G.; Brooks, R. C.; Wilson, B. C. The photophysical properties of a ruthenium-substituted phthalocyanine J. Photochem. Photobiol., B 1994, 26, 277-282
29. Carneiro, Z. A.; de Moraes, J. C. B.; Rodrigues, F. P.; de Lima, R. G.; Curti, C.; da Rocha, Z. N.; Paulo, M.; Bendhack, L. M.; Tedesco, A. C.; Formiga, A. L. B.; da Silva, R. S. Photocytotoxic activity of a nitrosyl phthalocyanine ruthenium complex-a system capable of producing nitric oxide and singlet oxygen J. Inorg. Biochem. 2011, 105, 1035-1043
30. Zhou, J.; Liu, J.; Feng, Y.; Wei, S.; Gu, X.; Wang, X.; Zhang, B. Synthesis and characterization of the monomer ruthenium complex of hypocrellin B Bioorg. Med. Chem. Lett. 2005, 15, 3067-3070
31. Zayat, L.; Noval, M. G.; Campi, J.; Calero, C. I.; Calvo, D. J.; Etchenique, R. A new inorganic photolabile protecting group for highly efficient visible light GABA uncaging ChemBioChem 2007, 8, 2035-2038
32. Salierno, M.; Fameli, C.; Etchenique, R. Caged amino acids for visible-light photodelivery Eur. J. Inorg. Chem. 2008, 1125-1128
33. 2+with visible light Chem. Commun. 2010, 46, 2426
34. Goldbach, R. E.; Rodriguez-Garcia, I.; van Lenthe, J. H.; Siegler, M. A.; Bonnet, S. N -Acetylmethionine and biotin as photocleavable protective groups for ruthenium polypyridyl complexes Chem.-Eur. J. 2011, 17, 9924-9929
35. Wachter, E.; Heidary, D. K.; Howerton, B. S.; Parkin, S.; Glazer, E. C. Light-activated ruthenium complexes photobind DNA and are cytotoxic in the photodynamic therapy window Chem. Commun. 2012, 48, 9649
36. Sgambellone, M. A.; David, A.; Garner, R. N.; Dunbar, K. R.; Turro, C. Cellular toxicity induced by the photorelease of a caged bioactive molecule: design of a potential dual-action Ru(II) complex J. Am. Chem. Soc. 2013, 135, 11274-11282
37. Lincoln, R.; Kohler, L.; Monro, S.; Yin, H.; Stephenson, M.; Zong, R.; Chouai, A.; Dorsey, C.; Hennigar, R.; Thummel, R. P.; McFarland, S. A. Exploitation of long-lived 3IL excited states for metal-organic photodynamic therapy: verification in a metastatic melanoma model J. Am. Chem. Soc. 2013, 135, 17161-17175
38. El-Hussein, A.; Harith, M.; Abrahamse, H. Assessment of DNA damage after photodynamic therapy using a metallophthalocyanine photosensitizer Int. J. Photoenergy 2012, 1-10
39. Casas, A.; Di Venosa, G.; Hasan, T.; Batlle, A. Mechanisms of resistance to photodynamic therapy Curr. Med. Chem. 2011, 18, 2486-2515
40. Li, F.; Mulyana, Y.; Feterl, M.; Warner, J. M.; Collins, J. G.; Keene, F. R. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA Dalton Trans. 2011, 40, 5032-5038
41. Li, F.; Feterl, M.; Mulyana, Y.; Warner, J. M.; Collins, J. G.; Keene, F. R. In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes J. Antimicrob. Chemother. 2012, 67, 2686-2695
42. Pandrala, M.; Li, F.; Feterl, M.; Mulyana, Y.; Warner, J. M.; Wallace, L.; Keene, F. R.; Collins, J. G. Chlorido-containing ruthenium(II) and iridium(III) complexes as antimicrobial agents Dalton Trans. 2013, 42, 4686-4694
43. Li, F.; Harry, E. J.; Bottomley, A. L.; Edstein, M. D.; Birrell, G. W.; Woodward, C. E.; Keene, F. R.; Collins, J. G. Dinuclear ruthenium(II) antimicrobial agents that selectively target polysomes in vivo Chem. Sci. 2014, 5, 685-693
44. IIPolypyridyl Complexes as Effective Photosensitizers in Photodynamic Therapy. Chem.-Eur. J. 2014, accepted, DOI: chem.201402796R2.
45. 2films Nature 1991, 353, 737-740
46. -) on nanocrystalline titanium dioxide electrodes J. Am. Chem. Soc. 1993, 115, 6382-6390
47. Jiang, K.-J.; Masaki, N.; Xia, J.-b.; Noda, S.; Yanagida, S. A novel ruthenium sensitizer with a hydrophobic 2-thiophen-2-yl-vinyl-conjugated bipyridyl ligand for effective dye sensitized TiO2 solar cells Chem. Commun. 2006, 2460-2462
48. Chen, C. Y.; Wu, S. J.; Li, J. Y.; Wu, C. G.; Chen, J. G.; Ho, K. C. A new route to enhance the light-harvesting capability of ruthenium complexes for dye-sensitized solar cells Adv. Mater. 2007, 19, 3888-3891
49. 2solar cells with a high solar-energy-conversion efficiency Adv. Funct. Mater. 2007, 17, 2964-2974
50. Chen, C.-Y.; Chen, J.-G.; Wu, S.-J.; Li, J.-Y.; Wu, C.-G.; Ho, K.-C. Multifunctionalized ruthenium-based supersensitizers for highly efficient dye-sensitized solar cells Angew. Chem., Int. Ed. 2008, 47, 7342-7345
51. Abbotto, A.; Barolo, C.; Bellotto, L.; Angelis, F. D.; Gratzel, M.; Manfredi, N.; Marinzi, C.; Fantacci, S.; Yum, J.-H.; Nazeeruddin, M. K. Electron-rich heteroaromatic conjugated bipyridine based ruthenium sensitizer for efficient dye-sensitized solar cells Chem. Commun. 2008, 5318-5320
52. Vougioukalakis, G. C.; Philippopoulos, A. I.; Stergiopoulos, T.; Falaras, P. Contributions to the development of ruthenium-based sensitizers for dye-sensitized solar cells Coord. Chem. Rev. 2011, 255, 2602-2621
53. Chou, C.-C.; Wu, K.-L.; Chi, Y.; Hu, W.-P.; Yu, S. J.; Lee, G.-H.; Lin, C.-L.; Chou, P.-T. Ruthenium(II) sensitizers with heteroleptic tridentate chelates for dye-sensitized solar cells Angew. Chem., Int. Ed. 2011, 50, 2054-2058
54. Islam, A.; Sugihara, H.; Arakawa, H. Molecular design of ruthenium(II) polypyridyl photosensitizers for efficient nanocrystalline TiO2 solar cells J. Photochem. Photobiol., C 2003, 158, 131-138
55. 2film by ruthenium(II) diimine dithiolate complexes J. Photochem. Photobiol., A 2001, 145, 135-141
56. Abrahamsson, M.; Jäger, M.; Kumar, R. J.; Österman, T.; Persson, P.; Becker, H.-C.; Johansson, O.; Hammarström, L. Bistridentate ruthenium(II)polypyridyl-type complexes with microsecond 3MLCT state lifetimes: sensitizers for rod-like molecular arrays J. Am. Chem. Soc. 2008, 130, 15533-15542
57. Medlycott, E. A.; Hanan, G. S. Designing tridentate ligands for ruthenium(II) complexes with prolonged room temperature luminescence lifetimes Chem. Soc. Rev. 2005, 34, 133-142
58. Noffke, A. L.; Habtemariam, A.; Pizarro, A. M.; Sadler, P. J. Designing organometallic compounds for catalysis and therapy Chem. Commun. 2012, 48, 5219-5246
59. Oehninger, L.; Alborzinia, H.; Ludewig, S.; Baumann, K.; Wölfl, S.; Ott, I. From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects? ChemMedChem 2011, 6, 2142-2145
60. DeRosa, M. C.; Crutchley, R. J. Photosensitized singlet oxygen and its applications Coord. Chem. Rev. 2002, 233-234, 351-371
61. Maestri, M.; Armaroli, N.; Balzani, V.; Constable, E. C.; Thompson, A. M. W. C. Complexes of the ruthenium(II)-2,2′:6′,2″-terpyridine family. Effect of electron-accepting and -donating substituents on the photophysical and electrochemical properties Inorg. Chem. 1995, 34, 2759-2767
62. 2-based solar cells J. Am. Chem. Soc. 2001, 123, 1613-1624
63. Barigelletti, F.; Flamigni, L.; Balzani, V.; Collin, J. P.; Sauvage, J. P.; Sour, A.; Constable, E. C.; Cargill Thompson, A. M. W. Intramolecular energy transfer through phenyl bridges in rod-like dinuclear Ru(II)/Os(II) terpyridine-type complexes Coord. Chem. Rev. 1994, 132, 209-214
64. Medlycott, E. A.; Hanan, G. S. Synthesis and properties of mono- and oligo-nuclear Ru(II) complexes of tridentate ligands: the quest for long-lived excited states at room temperature Coord. Chem. Rev. 2006, 250, 1763-1782
65. 2Inorg. Chem. 2006, 45, 4071-4078
66. Begum, R. A.; Farah, A. A.; Hunter, H. N.; Lever, A. B. P. Synthesis and characterization of ruthenium bis-bipyridine mono- and disulfinato complexes Inorg. Chem. 2009, 48, 2018-2027
67. Cave, G. W. V.; Raston, C. L. Efficient synthesis of pyridines via a sequential solventless aldol condensation and Michael addition J. Chem. Soc., Perkin Trans. 1 2001, 3258-3264
68. Jaeger, M.; Eriksson, L.; Bergquist, J.; Johansson, O. Synthesis and characterization of 2,6-di(quinolin-8-yl)pyridines. new ligands for bistridentate Ru(II) complexes with microsecond luminescent lifetimes J. Org. Chem. 2007, 72, 10227-10230
69. 2+complexes as sub-units in supramolecular architectures: the solubilized ligand 42-(4-carboxyphenyl)-4,43-di-(tert -butyl)tpy and its homoleptic Ru(II) complex Inorg. Chim. Acta 2008, 361, 2259-2269
70. 6-metal centres J. Chem. Soc., Dalton Trans. 2002, 4732-4739
71. Ishida, H.; Tobita, S.; Hasegawa, Y.; Katoh, R.; Nozaki, K. Recent advances in instrumentation for absolute emission quantum yield measurements Coord. Chem. Rev. 2010, 254, 2449-2458
72. Jenkins, Y.; Friedman, A. E.; Turro, N. J.; Barton, J. K. Characterization of dipyridophenazine complexes of ruthenium(II): the light switch effect as a function of nucleic acid sequence and conformation Biochemistry 1992, 31, 10809-10816
73. Pierroz, V.; Joshi, T.; Leonidova, A.; Mari, C.; Schur, J.; Ott, I.; Spiccia, L.; Ferrari, S.; Gasser, G. Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid J. Am. Chem. Soc. 2012, 134, 20376-20387
74. Patra, M.; Ingram, K.; Pierroz, V.; Ferrari, S.; Spingler, B.; Keiser, J.; Gasser, G. Ferrocenyl derivatives of the anthelmintic praziquantel: design, synthesis, and biological evaluation J. Med. Chem. 2012, 55, 8790-8798
75. Leonidova, A.; Pierroz, V.; Rubbiani, R.; Heier, J.; Ferrari, S.; Gasser, G. Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes Dalton Trans. 2014, 43, 4287-4294
76. Schmidt, R.; Tanielian, C.; Dunsbach, R.; Wolff, C. Phenalenone, a universal reference compound for the determination of quantum yields of singlet oxygen O2(1Δg) sensitization J. Photochem. Photobiol., A 1994, 79, 11-17
77. Kiesslich, T.; Gollmer, A.; Maisch, T.; Berneburg, M.; Plaetzer, K. A comprehensive tutorial on in vitro characterization of new photosensitizers for photodynamic antitumor therapy and photodynamic inactivation of microorganisms BioMed. Res. Int. 2013, 2013, 17
78. Wilkinson, F.; Helman, W. P.; Ross, A. B. Rate constants for the decay and reactions of the lowest electronically excited singlet state of molecular oxygen in solution. an expanded and revised compilation J. Phys. Chem. Ref. Data 1995, 24, 663-677
79. Delaey, E.; van Laar, F.; De Vos, D.; Kamuhabwa, A.; Jacobs, P.; de Witte, P. A comparative study of the photosensitizing characteristics of some cyanine dyes J. Photochem. Photobiol., B 2000, 55, 27-36
80. U.S. Food and Drug Administration; U.S. Food and Drug Administration: Silver Spring, MD; http://www.fda.gov (Accessed Jul 11, 2014).
81. Kennedy, J. C.; Pottier, R. H.; Pross, D. C. Photodynamic therapy with endogenous protoporphyrin: IX: basic principles and present clinical experience J. Photochem. Photobiol., B 1990, 6, 143-148
82. Dougherty, T. J. An update on photodynamic therapy applications J. Clin. Laser Med. Surg. 2002, 20, 3-7
83. Sherman, S. E.; Lippard, S. J. Structural aspects of platinum anticancer drug interactions with DNA Chem. Rev. 1987, 87, 1153-1181
84. Battersby, A. R.; Fookes, C. J.; Matcham, G. W.; McDonald, E. Biosynthesis of the pigments of life: formation of the macrocycle Nature 1980, 285, 17-21
85. Scolaro, L. M.; Castriciano, M.; Romeo, A.; Patané, S.; Cefali, E.; Allegrini, M. Aggregation behavior of protoporphyrin IX in aqueous solutions: clear evidence of vesicle formation J. Phys. Chem. B 2002, 106, 2453-2459
86. Muroya, T.; Suehiro, Y.; Umayahara, K.; Akiya, T.; Iwabuchi, H.; Sakunaga, H.; Sakamoto, M.; Sugishita, T.; Tenjin, Y. Photodynamic therapy (PDT) for early cervical cancer Cancer Chemother. 1996, 23, 47-56
87. Newmeyer, D. D.; Ferguson-Miller, S. Mitochondria: Releasing power for life and unleashing the machineries of death Cell 2003, 112, 481-490
88. Tan, C.; Wu, S.; Lai, S.; Wang, M.; Chen, Y.; Zhou, L.; Zhu, Y.; Lian, W.; Peng, W.; Ji, L.; Xu, A. Synthesis, structures, cellular uptake and apoptosis-inducing properties of highly cytotoxic ruthenium-Norharman complexes Dalton Trans. 2011, 40, 8611-8621
89. Oehninger, L.; Stefanopoulou, M.; Alborzinia, H.; Schur, J.; Ludewig, S.; Namikawa, K.; Munoz-Castro, A.; Koster, R. W.; Baumann, K.; Wolfl, S.; Sheldrick, W. S.; Ott, I. Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules Dalton Trans. 2013, 42, 1657-1666
90. Hamblin, M. R.; Hasan, T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004, 3, 436
91. Eichner, A.; Gonzales, F. P.; Felgentrager, A.; Regensburger, J.; Holzmann, T.; Schneider-Brachert, W.; Baumler, W.; Maisch, T. Dirty hands: photodynamic killing of human pathogens like EHEC, MRSA and Candida within seconds Photochem. Photobiol. Sci. 2013, 12, 135-147
92. Miles, A. A.; Misra, S. S.; Irwin, J. O. The estimation of the bactericidal power of the blood Epidemiol. Infect. 1938, 38, 732-749
93. Schastak, S.; Ziganshyna, S.; Gitter, B.; Wiedemann, P.; Claudepierre, T. Efficient photodynamic therapy against Gram-positive and Gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength PLoS One 2010, 5, e11674
94. Lei, W.; Zhou, Q.; Jiang, G.; Zhang, B.; Wang, X. Photodynamic inactivation of Escherichia coli by Ru(II) complexes Photochem. Photobiol. Sci. 2011, 10, 887-890
95. Agilent Technologies (formerly Oxford Diffraction), Yarnton, Oxfordshire, England, 2012.
96. Clark, R. C.; Reid, J. S. The analytical calculation of absorption in multifaceted crystals Acta Crystallogr., Sect. A: Found. Crystallogr. 1995, 51, 887-897
97. CrysAlisPro, version 1.171.36.20; Agilent Technologies: Yarnton, Oxfordshire, England, 2012.
98. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program J. Appl. Crystallogr. 2009, 42, 339-341
99. Palatinus, L.; Chapuis, G. SUPERFLIP-a computer program for the solution of crystal structures by charge flipping in arbitrary dimensions J. Appl. Crystallogr. 2007, 40, 786-790
100. Sheldrick, G. A short history of SHELX Acta Crystallogr., Sect. A: Found Crystallogr. 2008, 64, 112-122
101. Spek, A. Single-crystal structure validation with the program PLATON J. Appl. Crystallogr. 2003, 36, 7-13
102. Muramatsu, M.; Smetana, K.; Busch, H. Quantitative aspects of isolation of nucleoli of the walker carcinosarcoma and liver of the rat Cancer Res. 1963, 23, 510-518
103. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
104. Boyce, J. M.; Pittet, D. Guideline for hand hygiene in health-care settings: recommendations of the healthcare infection control practices advisory committee and the hicpac/shea/apic/idsa hand hygiene task force Am. J. Infect. Control 2002, 30, S1-S46